Strides Pharma to buy 54 percent stake in SteriScience for Rs 135 crore
The investment in SteriScience will allow Strides to leverage its expertise and experience in the high- value injectables business.;
Advertisement
New Delhi: Drug firm Strides Pharma Science on Monday said it will invest Rs 135 crore over the next 24 months to acquire around 54 percent stake in SteriScience Pharma Pvt Ltd.
This will make SteriScience the company''s dedicated arm for global sterile injectables business, Strides Pharma Science said in a filing to the BSE.
The investment in SteriScience will allow Strides to leverage its expertise and experience in the high-value injectables business. SteriScience is designed for a global foray in sterile injectables leveraging the group''s rich experience in the domain, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.